Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis-Reference-Cited by-同舟云学术

Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis

Published:2021-08-18 Issue:9 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Dixit Keerti Kaumudee¹²,Ramesh V.³,Upadhyay Shreya⁴,Singh Abhishek Kumar⁴,Singh Om Prakash⁴,Sundar Shyam⁴,Singh Ruchi¹^ORCID,Salotra Poonam¹^ORCID

Affiliation:

1. ICMR-National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, India

2. Faculty of Health and Biological Sciences, Symbiosis International (Deemed University), Pune, India

3. Department of Dermatology and STD, Safdarjung Hospital, New Delhi, India

4. Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India

Abstract

The countries in the Indian subcontinent have reported a dramatic decline in visceral leishmaniasis (VL) cases. However, the presence of the parasite reservoir in the form of post-kala-azar dermal leishmaniasis (PKDL), a dermal sequel of VL, is a hurdle in attaining VL elimination.

Funder

Indian Council of Medical Research

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00132-21

Reference33 articles.

1. Post kala-azar dermal leishmaniasis: A threat to elimination program

2. Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.

3. Clinical Epidemiologic Profile of a Cohort of Post–Kala-Azar Dermal Leishmaniasis Patients in Bihar, India